Pillow with retractable umbrella
A pillow assembly having a supporting assembly and a retractable umbrella assembly that is easily transportable and allows a user to support his/her head while covering their face from sunlight.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5407684 | Use of DHEA as a medicinal Dehydroepiandrosterone (DHEA) has an immune response regulating effect in vertebrates to protect from morbid effect of infection and immune suppressive therapies. DHEA is also effective for use in treatment of alopecia. Protection results from a generaliz... | 04/18/1995 |
| 5403859 | Heterocyclic derivatives The invention concerns a heterocyclic derivative of the formula I, ##STR1## wherein Ar1 is optionally substituted phenyl or naphthyl; A1 is (1-6C)alkylene, (1-6C)alkenylene, (3-6C)alkynylene or cyclo-(3-6C)alkylene; Ar2 is... | 04/04/1995 |
| 5401773 | Lactic acid acylates All possible isomeric forms, racemic mixtures and enantiomeric and diastereoisomeric forms of a compound selected from the group consisting of a compound of the formula ##STR1## wherein R is alkenyl of 10 carbon atoms, n is an integer from 1 to 3 and... | 03/28/1995 |
| 5401777 | Use of preparations of curcuma plants The invention relates to the use of preparations of the plant Curcuma longa or other curcumin-containing plants, curcumin or curcumin derivatives for the prophylaxis and/or treatment of conditions associated with excessive formation of leucotrienes and/or... | 03/28/1995 |
| 5397778 | Enteral formulations for treatment of inflammation and infection The present invention features saponin containing enteral formulations for treatment of infection and inflammation. These saponin containing formulations are particularly useful in conjunction with oils rich in ω3 polyunsaturated fatty acids such as fish... | 03/14/1995 |
| 5393790 | Substituted spiro compounds for the treatment of inflammation A class of substituted spiro compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula III: ##STR1## wherein n is a number selected from 0, 1 and 2; wherein R | 02/28/1995 |
| 5387576 | Treatment of hyperproliferative epidermal conditions with activin A Pharmaceutical preparations for the treatment of hyperproliferative epidermal conditions comprising the specific negative growth factor activin A, and their use in methods of treatment of hyperproliferative epidermal conditions.... | 02/07/1995 |
| 5376633 | Method for deactivating viruses in blood component containers The present invention provides a method for inhibiting viral proliferation by preventing or inhibiting viral replication or killing the viruses on contact. Viral replication is prevented or inhibited through the use of serine protease inhibitors, their an... | 12/27/1994 |
| 5369131 | Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam A liquid pharmaceutical composition which can be administered as a foam by means of suitable supplying devices, without necessity of gas propeller, said composition consisting of: a) one or more natural or synthetic ionic or non ionic, acid, basic or neut... | 11/29/1994 |
| 5362732 | Boronated compounds A novel class of pharmaceutically active boronated compounds are provided. The boronated compounds include boronated purine and pyrimidine bases and boronated nucleosides, as well as phosphate esters and oligomers thereof. The compounds are boronated at t... | 11/08/1994 |
| 5356633 | Method of treatment of inflamed tissues A method of and composition for concentrating a therapeutic agent in an inflamed dermal region are disclosed. The composition, which is also used in the method, is a liposomal composition. The liposomes contain the therapeutic agent in entrapped form and ... | 10/18/1994 |
| 5348729 | Evaluative means for detecting inflammatory reactivity The present invention is directed to a method for testing the susceptibility of a mammal to inflammatory diseases which comprises the steps of: administering to a mammal a compound selected from the group consisting of Type 1 mineralocorticoid receptor an... | 09/20/1994 |
| 5348956 | Substituted cyclopropylamino-1,3,5-triazines New substituted cyclopropylamino-1,3,5-triazines having the formula ##STR1## wherein R1 is C1 -C3 -alkyl, C3 -C5 -cycloalkyl or C1 -C3 -alkyl-C3 -C5 -cycloa... | 09/20/1994 |
| 5342615 | Method for treating arthritis or inflammation with Il-1 or derivatives thereof Interleukin-1 (IL-1-) and derivatives, and their pharmaceutical compositions for use in treating arthritis or inflammation.... | 08/30/1994 |
| 5342614 | Method of treating arthritus or inflammation with IL-1ଲ or derivatives thereof Interleukin-1ଲ (IL-1ଲ) and derivatives, and their pharmaceutical compositions for use in treating arthritis or inflammation.... | 08/30/1994 |
| 5322839 | Protein fraction for cosmetic and dermatology care of the skin The protein fraction from Leguminosae seeds, which is characterized by at least one band in polyacrylamide gel electrophoresis with sodium dodecyl sulfate, by relative molecular masses from 3,000 to 30,000 g/mole, by a content of total nitrogen of 14 to 2... | 06/21/1994 |
| 5314877 | Water-soluble pentacyclic triterpene composition and method for producing the same Disclosed is water-soluble composition made by subjecting pentacyclic triterpene compound belonging to amylin group such as oleanolic acid, ursolic acid and hederagenin to inclusion in cyclodextrins. Though the aforementioned pentacyclic triterpene compou... | 05/24/1994 |
| 5288704 | Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharm... | 02/22/1994 |
| 5284873 | Pharmaceutical compositions derived from the acid fraction of lipid extracts of sabal serrulata, with adrenergic antagonist activity and method of preparing said composition The new compositions of the invention are formed by the total acid fraction obtained by alkali hydrolysis of the lipid extracts of the fruit of Sabal serrulata. Said compositions have an effective adrenergic antagonist action and a complementary antiinfla... | 02/08/1994 |
| 5284826 | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins Hydroxy-substituted [(D)Ser]8 -Ciclosporin derivatives, particularly [O-(2-hydroxyethyl)(D)Ser]8 -Ciclosporin, have advantageous pharmacological properties and are useful as immunosuppressants, for example in the treatment of transpl... | 02/08/1994 |
| 5283262 | Phenethanolamine derivatives The invention provides compounds of the general formula (I) ##STR1## or a physiologically acceptable salt or solvate thereof, wherein Q represents a 1- or 2-naphthalenyl group. The compounds have a stimulant action at 댢 -adrenoreceptors ... | 02/01/1994 |
| 5281623 | Method for treating inflammation Provided are methods of treating inflammation, arthritis and muscular dystrophy and preventing ischemia-induced cell damage employing certain phenol and benzamide compounds.... | 01/25/1994 |
| 5281608 | Substituted tetrahydropyrido[3',4':4,5]-pyrrolo[3,2-c]quinolines There are disclosed compounds of the formula ##STR1## wherein R is hydrogen, lower alkyl or phenyl; R1 is hydrogen, lower alkyl, phenyl, halo, hydroxy, lower alkoxy or trifluoromethyl; R2 is phenyl, phenylloweralkyl, thienyl, furyl, ... | 01/25/1994 |
| 5276061 | Cosmetic compositions containing 1-hydroxyvitamin D homologs Compositions containing 1-hydroxyvitamin D homolog compounds in a suitable carrier and methods employing such compositions are disclosed for cosmetic uses in the treatment of various skin conditions such as lack of adequate skin firmness, wrinkles,... | 01/04/1994 |
| 5273747 | Commiphora mukul extracts and therapeutical applications thereof The present invention relates to new therapeutic uses of lipophilic extracts of Commiphora mukul, prepared from exudate of said plant, as well as the preparation of pure compounds or highly standardized fractions thereof as active ingredients. The extract... | 12/28/1993 |
| 5266562 | Anti-inflammatory agents Synthetic oligopeptides having potent anti-inflammatory and phospholipase A2 inhibiting properties are described. A method of controlling inflammation of body tissue is also described.... | 11/30/1993 |
| 5262161 | Stevia extract-containing medicine A medicine for skin diseases contains a fermented and condensed extract from the stems of Stevia Rebaudiana Bertoni as an active ingredient. The medicine is prepared by condensing and fermenting an extract from the ripened stems of Stevia Rebaudiana Berto... | 11/16/1993 |
| 5260341 | Product and process for treating bovine mastitis and bovine metritis A product for treating bovine mastitis and bovine metritis includes mixture of diacetyl and acetoin. The diacetyl and acetoin is produced by fermentation of milk and is then distilled and concentrated. The concentrated mixture of diacetyl and acetoin is i... | 11/09/1993 |
| 5258391 | Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use Therapeutic as well as preventative measures to improve the cosmetic conditions or to alleviate the symptoms of dermatologic disorders with phenyl alpha acyloxyalkanoic acids and derivatives is disclosed. The cosmetic conditions and dermatologic disorders... | 11/02/1993 |
| 5256403 | Composition and method for protecting the skin from UV-rays Solubilized melanin based compositions supply melanin to skin, scalp and/or hair. The compositions consist of melanin, as an active ingredient, and a substance to solubilize the melanin blended together in a vehicle suitable for topical application. A mel... | 10/26/1993 |
| 5250301 | Method for treating digestive organ disorders A liquid internal medicine contains only an extract from stems of natural Stevia plants. The medicine is particularly effective for curing disorders of the digestive organs. The medicine contains a liquid obtained by fermenting a concentrate of an extract... | 10/05/1993 |
| 5250300 | Method for treating digestive organ disorders of domestic animals A liquid internal medicine for domestic animals contains only an extract from stems of natural Stevia plants. The medicine is effective for curing disorders of the digestive organs of domestic animals and for improving the physical constitution of domesti... | 10/05/1993 |
| 5246964 | Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters A method of treatment of inflammatory diseases which comprises administering, to a subject in need of such treatment, an anti-inflammatory effective amount of a polyoxyethylenesorbitan mono-higher-fatty acid ester.... | 09/21/1993 |
| 5244899 | Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders The compounds of this invention are azabicyclic and azatricyclic amides represented by the formula: ##STR1## wherein: R1 and R2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a ... | 09/14/1993 |
| 5244917 | Substituted naphthofurans as anti-inflammatory agents This invention relates to substituted naphthofurans as anti-inflammatory and anti-allergic agents, pharmaceutical compositions containing them, processes for their preparation, and their use as anti-inflammatory and anti-allergic agents. The naphthofurans... | 09/14/1993 |
| 5238965 | Methods of using lysophosphatidic acids for regulating skin wrinkles The subject invention relates to methods for regulating wrinkles in mammalian skin comprising topical application of a lysophosphatidic acid compound having the structure: ##STR1## or a cyclic derivative thereof having the structure: ##STR2## ... | 08/24/1993 |
| 5229421 | Methods and compositions for inhibiting lipoxygenase This invention encompasses compounds and pharmaceutical compositions comprising a pharmaceutical carrier and an effective lipoxygenase inhibiting amount of a compound of the formula: ##STR1## wherein R1 and R2 are the same or di... | 07/20/1993 |
| 5223539 | N,N-Di-alkyl(phenoxy)benzamide derivatives The present invention relates to compounds of the formula: ##STR1## and the pharmaceutically acceptable salts thereof, wherein Z can be: ##STR2## wherein R3 is alkyl having 1 to 6 carbon atoms and, when n is greater than 1, each R | 06/29/1993 |
| 5215979 | 16,17-acetalsubstituted pregnane 21-oic acid derivatives The invention refers to compounds having activity against inflammatory, allergic, and dermatological conditions. The compounds are characterized by the formula ##STR1## or a stereoisomeric component thereof, in which formula R1 is sel... | 06/01/1993 |
| 5214070 | Diaryl ether cycloalkanes The invention concerns a diaryl ether cycloalkane of the formula I, or a pharmaceutically-acceptable salt thereof, ##STR1## wherein Ar1 is optionally substituted phenyl or naphthyl; X1 is oxy, thio, sulphinyl or sulphonyl; Ar | 05/25/1993 |